Wafik S. El-Deiry: Honored to join International Panel and Tour Leading Research Institutes in Qatar
Wafik S. El-Deiry shared a post on LinkedIn:
”Honored to participate as part of an international panel and tour the Translational Research Institute at Hamad Ben Khalifa Medical City, Qatar Diabetes Research Center, the Clinical Trials Unit and Center for Clinical Precision Medicine and Genomics, Sidra Medicine, Qatar Foundation, and Qatar Biomedical Research Institute.
A lot has been going on to build infrastructure for over a decade with many opportunities for impact in the region and globally. The tours were impressive in terms of available technologies for basic and clinical research.
Looking forward to review the Cancer Research Institute and to visit the National Center of Cancer Care and Research (NCCCR) tomorrow.”
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023